Physician profile
Omar A Minai
NPI 1508820986
$1,320,031.06
in general payments reported to CMS, 2019-2025
45 companies · $220K in 2025
The $220K reported for 2025 was more than what 99% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130K · 2020: $76K · 2021: $185K · 2022: $194K · 2023: $193K · 2024: $323K · 2025: $220K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $665K · Travel and Lodging: $50K · Food and Beverage: $15K · Consulting Fee: $5,598 · Education: $410 · Gift: $17.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $664,941.25 |
| Travel and Lodging | $49,990.18 |
| Food and Beverage | $15,149.00 |
| Consulting Fee | $5,598.03 |
| Education | $409.70 |
| Gift | $17.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $474,791.08 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Actelion Pharmaceuticals US, INC. | $444,411.69 | 2019-2025 | Uptravi, Opsumit |
| Glaxosmithkline, LLC. | $219,690.14 | 2019-2025 | Arexvy, Nucala, Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $50,853.01 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $48,114.95 | 2020-2025 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30,225.00 | 2019-2024 | Ofev |
| Merck Sharp & Dohme LLC | $23,652.00 | 2023-2025 | Winrevair, Zerbaxa |
| Mallinckrodt Enterprises LLC | $18,736.93 | 2019 | |
| Ani Pharmaceuticals, INC. | $3,762.12 | 2023-2025 | Purified Cortrophin Gel |
| Viiv Healthcare Company | $1,600.00 | 2019 | |
| Sunovion Pharmaceuticals INC. | $1,369.66 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $533.70 | 2021-2025 | Dupixent, Libtayo |
| Grifols USA, LLC | $353.38 | 2019-2024 | Prolastin-C Liquid |
| Abbvie INC. | $139.96 | 2022-2025 | |
| Seagen INC. | $125.00 | 2021 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $117.77 | 2019-2025 | |
| Biomerieux INC | $116.90 | 2019-2022 | |
| Mylan Specialty L.P. | $105.85 | 2020-2024 | Yupelri |
| Genzyme Corporation | $105.33 | 2021-2025 | |
| Philips North America LLC | $95.84 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Allergan, INC. | $90.35 | 2019 | |
| Jazz Pharmaceuticals INC. | $90.05 | 2020-2025 | |
| Electromed, INC. | $88.44 | 2022-2024 | Smartvest |
| Vifor Pharma, INC. | $74.21 | 2024 | Zemaira |
| Advanced Respiratory, INC | $68.73 | 2020-2021 | |
| Verona Pharma, INC. | $65.43 | 2025 | Ohtuvayre |
| Inogen, INC. | $62.17 | 2021-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Janssen Pharmaceuticals, INC | $56.33 | 2021-2023 | Xarelto |
| Pulmonx Corporation | $55.42 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Shire North American Group INC | $53.19 | 2019 | |
| United Therapeutics Corporation | $48.41 | 2021-2025 | Tyvaso |
| Genentech USA, INC. | $45.85 | 2019-2024 | Xolair |
| Circassia INC. | $44.51 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.57 | 2021-2024 | Glassia |
| Lilly USA, LLC | $38.62 | 2025 | Zepbound |
| Paratek Pharmaceuticals, INC. | $31.54 | 2021-2022 | |
| Viatris Specialty LLC | $30.37 | 2025 | Yupelri |
| Inspire Medical Systems, INC. | $27.75 | 2023 | Inspire |
| Pharming Healthcare, INC. | $19.90 | 2023 | Ruconest |
| Insmed, INC. | $18.58 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $18.06 | 2021 | |
| Axsome Therapeutics, INC. | $15.95 | 2022 | |
| Tactile Systems Technology INC | $15.24 | 2022 | |
| Baxter Healthcare | $15.19 | 2024 | Hillrom - Monarch Airway Clearance System |
| Amgen INC. | $13.89 | 2023 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Minai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.